OSUR · Orasure Technologies Inc · Webcasts, Transcripts & Audio
$3.97
+0.09 (+2.19%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$271.05M
Shares
68.97M
Volume · Oct 2
420.75K
Avg daily vol (3M)
479.26K
Orasure Technologies Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Orasure Technologies Inc (OSUR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲116%
$116.46M
$5.59M
'22 Q3
22-11-08
▲93.6%
$123.08M
−$31.36M
'22 Q4
23-02-14
▲128.9%
$154.96M
$27.22M
'23 Q1
23-05-10
▲6.5%
$85.44M
−$4.80M
'23 Q2
23-08-03
▼23.4%
$89.19M
$11.16M
'23 Q3
23-11-07
▼38.3%
$75.88M
$20.07M
'23 Q4
24-02-27
▼65.1%
$54.13M
−$3.58M
'24 Q1
24-05-08
▼36.4%
$54.34M
−$615,000
'24 Q2
24-08-06
▼55.2%
$39.91M
−$4.51M
'24 Q3
24-11-06
▼50.7%
$37.45M
−$10.79M
'24 Q4
25-02-25
▼44.7%
$29.93M
−$16.04M
'25 Q1
25-05-07
▼42.5%
$31.24M
−$19.69M
'25 Q2
25-08-05
▼32.1%
$27.09M
−$13.71M
'25 Q3
25-11-05
▼28.5%
$26.76M
−$19.29M
'25 Q4
26-02-25
▼6.7%
$27.93M
−$22.38M
'26 Q1
26-05-06
LATEST
▼1.9%
$30.64M
$6.25M
'26 Q2
26-08-05
Earnings call
FY26 · Q2
2026-08-05
Orasure Technologies Inc (OSUR) Q2 2026 Earnings Call Transcript
Positive tone
COLE-PDX / ColiP-DX STI product launch
IntelliQuick CTNG FDA delay
Revenue performance and guidance
Revenue
$30.64M
▼ 1.9% YoY Diluted EPS
$0.09
Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Orasure Technologies Inc (OSUR) Q1 2026 Earnings Call Transcript
Positive tone
FDA submissions and product launches
International Diagnostics and near-shoring
Gross margin expansion
Revenue
$27.93M
▼ 6.7% YoY Diluted EPS
$-0.32
Gross margin
42.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Orasure Technologies Inc (OSUR) Q4 2025 Earnings Call
Positive tone
Product pipeline and FDA submissions
International expansion and nearshoring
BiMedomics / Sickle SCAN integration
Revenue
$26.76M*
▼ 28.5% YoY Gross margin
41.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Orasure Technologies Inc (OSUR) Q3 2025 Earnings Call Transcript
Balanced tone
BioMedomics acquisition and Sickle SCAN
Financial guidance and cost discipline
Innovation pipeline and Sherlock platform
Revenue
$27.09M
▼ 32.1% YoY Diluted EPS
$-0.19
Gross margin
43.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Orasure Technologies Inc (OSUR) Q2 2025 Earnings Call Transcript
Balanced tone
HEMAcollect PROTEIN product launch
Sample Management / consumer genetics customer
Together Take Me Home federal program
Revenue
$31.24M
▼ 42.5% YoY Diluted EPS
$-0.26
Gross margin
42.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Orasure Technologies Inc (OSUR) Q1 2025 Earnings Call Transcript
Balanced tone
Public health funding and aid disruption (PEPFAR/USAID/NIH)
Together Take Me Home program
Capital deployment: share repurchase and M&A
Revenue
$29.93M
▼ 44.7% YoY Diluted EPS
$-0.21
Gross margin
41.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Orasure Technologies Inc (OSUR) Q4 2024 Earnings Call Transcript
Balanced tone
International diagnostics / donor funding uncertainty
Core revenue growth
NIH research funding risk
Revenue
$37.45M*
▼ 50.7% YoY Gross margin
36.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Orasure Technologies Inc (OSUR) Q3 2024 Earnings Call Transcript
Positive tone
Operating efficiency and gross margin expansion
Proteomics / Blood sample management launch
International / WHO prequalification
Revenue
$39.91M
▼ 55.2% YoY Diluted EPS
$-0.06
▼ 140% YoY Gross margin
42.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Orasure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript
Positive tone
Gross margin headwinds and diversification
Core revenue and guidance
COVID-19 / InteliSwab contract completion
Revenue
$54.34M
▼ 36.4% YoY Diluted EPS
$-0.01
Gross margin
45.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Orasure Technologies Inc (OSUR) Q1 2024 Earnings Call Transcript
Positive tone
Restructuring and cost reduction
Balance sheet and cash flow
Strategic partnerships
Revenue
$54.13M
▼ 65.1% YoY Diluted EPS
$-0.05
▼ 113.5% YoY Gross margin
44.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Orasure Technologies Inc (OSUR) Q4 2023 Earnings Call Transcript
Positive tone
Distribution partnerships and portfolio expansion
HIV and sexual health
COVID-19 / InteliSwab
Revenue
$75.88M*
▼ 38.3% YoY Gross margin
46.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Orasure Technologies Inc (OSUR) Q3 2023 Earnings Call Transcript
Revenue
$89.19M
▼ 23.4% YoY Diluted EPS
$0.15
▲ 87.5% YoY Gross margin
49.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Orasure Technologies Inc (OSUR) Q2 2023 Earnings Call Transcript
Revenue
$85.44M
▲ 6.5% YoY Diluted EPS
$-0.07
Gross margin
30.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Orasure Technologies Inc (OSUR) Q1 2023 Earnings Call Transcript
Revenue
$154.96M
▲ 128.9% YoY Diluted EPS
$0.37
Gross margin
42.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-14
Orasure Technologies Inc (OSUR) Q4 2022 Earnings Call Transcript
Revenue
$123.08M*
▲ 93.6% YoY Gross margin
40.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Orasure Technologies Inc (OSUR) Q3 2022 Earnings Call Transcript
Revenue
$116.46M
▲ 116% YoY Diluted EPS
$0.08
Gross margin
39.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Orasure Technologies Inc (OSUR) Q2 2022 Earnings Call Transcript
Revenue
$80.23M
▲ 39.3% YoY Diluted EPS
$-0.26
Gross margin
34.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Orasure Technologies Inc (OSUR) Q1 2022 Earnings Call Transcript
Revenue
$67.71M
▲ 15.6% YoY Diluted EPS
$-0.28
▼ 660% YoY Gross margin
35.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Orasure Technologies Inc (OSUR) Q4 2021 Earnings Call Transcript
Revenue
$63.57M*
▲ 1.1% YoY Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Orasure Technologies Inc (OSUR) Q3 2021 Earnings Call Transcript
Revenue
$53.92M
▲ 12.3% YoY Diluted EPS
$-0.21
▼ 2200% YoY Gross margin
39.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Orasure Technologies Inc (OSUR) Q2 2021 Earnings Call Transcript
Revenue
$57.61M
▲ 96.9% YoY Diluted EPS
$-0.02
Gross margin
53.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Orasure Technologies Inc (OSUR) Q1 2021 Earnings Call Transcript
Revenue
$58.58M
▲ 85.4% YoY Diluted EPS
$0.05
Gross margin
65.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-01
Orasure Technologies Inc (OSUR) Q4 2020 Earnings Call Transcript
Revenue
$62.85M*
▲ 26.6% YoY Gross margin
60.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Orasure Technologies Inc (OSUR) Q3 2020 Earnings Call Transcript
Revenue
$48.01M
▲ 33.4% YoY Diluted EPS
$0.01
▼ 95.2% YoY Gross margin
63.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Orasure Technologies Inc (OSUR) Q2 2020 Earnings Call Transcript
Revenue
$29.26M
▼ 24.6% YoY Diluted EPS
$-0.16
▼ 328.6% YoY Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Orasure Technologies Inc (OSUR) Q1 2020 Earnings Call Transcript
Revenue
$31.60M
▲ 4.9% YoY Diluted EPS
$-0.12
Gross margin
51.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-19
Orasure Technologies Inc (OSUR) Q4 2019 Earnings Call
Revenue
$49.67M
▼ 1.2% YoY Diluted EPS
$0.04
▼ 75% YoY Gross margin
60.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 webcasts